.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Lilos is stocked at 22 licensed dispensaries across Massachusetts, with the deepest coverage in Easthampton, Quincy, Somerville, Attleboro, and Brockton. Search by ZIP code or city below to find the closest one.
Market Insights Snapshot
In July 2026, Lilos operated as a single-category brand with Edible accounting for 100.0% of sales, pairing a year-over-year sales change of 14.2% with a month-over-month decline of 7.7%, while average price fell 23.5% year over year. Within Massachusetts Edibles, the brand held rank 46, indicating that the current mix is concentrated and sensitive to intra-quarter pullbacks even as annual momentum remains positive; this pattern implies that Lilos is using price to drive volume in Edibles but has limited category hedging if monthly softness persists.
The combination of a 23.5% average price reduction alongside a 14.2% annual sales lift and a 7.7% monthly decline positions Lilos as a value-leaning Edible player whose demand elasticity is favorable year over year but exposed to short-term volatility at rank 46 in Massachusetts. With 100.0% of revenue in Edibles, the brand is trading margin for share and relying on pricing to convert, which implies that near-term stabilization likely requires mix expansion within Edibles’ subsegments or tighter price discipline to prevent further month-over-month erosion while protecting the annual gain.
Competitive Landscape
Lilos sits at rank #46 in Massachusetts Edible for July 2026, down 2 positions from #44 year over year, while improving 4 spots versus April 2026’s #50; this places it 4 ranks below its October 2025 peak of #42 and signals a shallow decline over twelve months paired with recent quarter-on-quarter stabilization. In contrast, Camino rose from #2 to #1 with a 42.7% year-over-year sales increase, and Wyld climbed from #5 to #3 alongside a 29.5% lift, indicating that competitors converting double‑digit growth are displacing mid‑tier share. The pattern of a 2-rank YoY slip against peers posting 18.6% to 42.7% gains implies that Lilos must outpace category growth to avoid sliding further from its #42 peak toward the mid‑50s.
Notable Products
CBG/THC 1:1 Mandarin Orange Yuzu Fruit Gummies 20-Pack (100mg CBG, 100mg THC) delivered the standout move in July 2026 with an 86.8% MoM surge to rank 7, while THC/CBD/CBN 1:1:1 Sleepy Cherry Gummies 20-Pack (100mg THC, 100mg CBD, 100mg CBN) dropped 18.3% and sat tied at rank 2; this split implies shoppers are rotating into CBG-forward formats even as flagship sleep blends retrench. At the top, CBG/THC 1:1 Mandarin Orange Yuzu Fruit Chews 20-Pack (100mg CBG, 100mg THC) held rank 1 despite a 4.9% decline, and Indica Blackberry Sage Gummies 20-Pack (100mg) slid 12.1% at rank 3; at least four of the top ten are gummies or chews within the Edible category, showing concentrated demand in chewy formats. With most legacy SKUs down between 5.6% and 18.9% and the new CBG/THC gummy rising 86.8%, the mix points to Lilos tilting assortment toward minor-cannabinoid gummies to capture momentum rather than doubling down on sleep-specific blends.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
